Increasing Public Awareness and Provider Education about Primary Immunodeficiency Disease

 

The purpose of the program is to strengthen the nation?s capacity to carry out public health activities in the area of primary immunodeficiency diseases (PID) by increasing and improving physician education and public health awareness for/of PID. The intent is to disseminate educational information on a national level to health care providers, educators, third-party payers, impacted families, and others who may help expedite clinical recognition and improve health outcomes for Americans with primary immunodeficiency diseases.

General information about this opportunity
Last Known Status
Active
Program Number
93.980
Federal Agency/Office
Centers For Disease Control and Prevention, Department of Health and Human Services
Type(s) of Assistance Offered
B - Project Grants
Program Accomplishments
Not applicable.
Authorization
317(k)(2) of Public Health Service Act, 42 USC 247 b (K)(2), 12372
Who is eligible to apply/benefit from this assistance?
Applicant Eligibility
Applicants with experience in: conducting effective physician education and public awareness campaigns for primary immunodeficiency diseases, collaborating effectively with health care and public health partners, and maximizing resources dedicated to campaign materials development and distribution to meet outcome goals.
Beneficiary Eligibility
The general public will benefit from outcome of this program.
Credentials/Documentation
Refer to the Notice of Funding Opportunity for requirements.
What is the process for applying and being award this assistance?
Pre-Application Procedure
Preapplication coordination is not applicable.
Application Procedure
This program is excluded from coverage under 2 CFR 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards.
Award Procedure
After review and approval, a Notice of Award (NoA) will be prepared and processed, along with appropriate notification to the public. Initial awards provide funds for the first budget period (usually 12 months) and the NoA will indicate support recommended for the remainder of the project period, allocation of Federal funds by budget categories, award requirements, and special conditions, if any.
Deadlines
July 20, 2017 to July 19, 2022 Contact the headquarters or regional location, as appropriate for application deadlines
Approval/Disapproval Decision Time
From 90 to 120 days.
Appeals
Not applicable.
Renewals
Project period of performance is 1 to 5 years. After initial awards, and subject to availability of funds, projects may be continued non-competitively contingent upon satisfactory progress by the recipient (as documented in required reports) and the determination that continued funding is in the best interest of the Federal government.
How are proposals selected?
Applicants will be evaluated on the review criteria described in the NOFO. See the NOFO for additional details.
How may assistance be used?
Financial Assistance will not be used for research activities. Funding for this grant will be used to reduce the burden of primary immunodeficiency diseases. Funding for activities should be allocated per the strategy to best meet the short, medium, and long term outcome goals.
What are the requirements after being awarded this opportunity?
Reporting
Performance Reports: Annual Federal Financial Reports (FFR) and performance/progress reports are required. Final FFRs and performance reports are required. Other reporting may be required and will be outlined in the NOFO or the Notice of Award.
Auditing
Not applicable.
Records
In accordance with 2 CFR ?200, as codified in 45 CFR ?75, there is a 3-year record retention requirement; records shall be retained beyond the 3-year period if final audit has not been done or findings resolved. Property records must be retained in accordance with HHS Grants Policy Statement requirements.
Other Assistance Considerations
Formula and Matching Requirements
Statutory formula is not applicable to this assistance listing.

Matching requirements are not applicable to this assistance listing.

MOE requirements are not applicable to this assistance listing.
Length and Time Phasing of Assistance
Financial assistance is provided for a 12-month budget period with a period of performance of up to five years subject to the availability of funds and satisfactory progress of the recipient. Notice of Award
Who do I contact about this opportunity?
Regional or Local Office
None/Not specified.
Headquarters Office
Scott Bowen
1600 Clifton Road
Altanta, GA 30329 US
sbowen1@cdc.gov
Phone: 404-498-0068
Fax: 404-498-0140

Salaria Allen
1600 Clifton Rd, NE
Mailstop H21-8
Atlanta, GA 30333 USA
gwh8@cdc.gov
Phone: 404-498-6043
Website Address
http://WWW.CDC.GOV
Financial Information
Account Identification
75-0959-0-1-550
Obligations
(Project Grants) FY 22$2,800,000.00; FY 23 est $2,800,000.00; FY 24 est $2,800,000.00; FY 21$2,800,000.00; FY 20$1,904,500.00; -
Range and Average of Financial Assistance
The range and average award is $921, 500.
Regulations, Guidelines and Literature
Not applicable.
Examples of Funded Projects
Not applicable.

 



Federal Grants Resources